Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Computational Statistics and Data Analysis Module Development

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541611
New
Federal
Community Reentry Network
Solicitation # 15BNAS26R00000020
The Department of Justice, through the Federal Bureau of Prisons (BOP) Chaplaincy Services Branch, is soliciting a firm-fixed-price contract to develop and maintain the Community Reentry Network (CRN). This agency-wide electronic clearinghouse is designed to facilitate reentry referrals and mentoring support for inmates by locating, vetting, and entering faith-based organizations (FBOs) into a database. The contractor is responsible for identifying resources, confirming their ability to meet ex-offender needs, and performing annual reverifications. A key performance requirement for the base year includes adding at least 750 new FBOs per month, with a specific focus on underserved areas such as rural locations, Puerto Rico, Guam, Native American reservations, and Hispanic communities. The contract structure consists of a 12-month base period with four 12-month option years and a potential six-month extension. This is a total small business set-aside under NAICS 541611. The contractor must provide a specialized team, including at least one doctoral-level member in theology, sociology, or psychology, a fluent Spanish speaker, and a Native American team member. Evaluation will be based on a best-value tradeoff, where ten technical factors—including organizational experience, language proficiency, and outreach strategies—are significantly more important than price. Proposals must be submitted via SAM.gov by the extended deadline of September 21, 2026, at 12:00 noon EST.
National Acquisitions - Co

POSTED

about 13 hours ago

DEADLINE

in 3 days
NAICS: 541611
New
Federal
Risk Management, Financial Analysis and Administrative Support Services
Solicitation # 47QACA26R0306
Solicitation 47QACA26R0306 is a request for proposal for a single-award indefinite delivery, indefinite quantity contract to provide risk management, financial analysis, and administrative support services for the Small Business Administration Office of Capital Access, specifically the Office of Credit Risk Management. This is a 100 percent set-aside restricted to responsible SBA-certified Women-Owned Small Businesses under NAICS code 541611. The contract consists of a base year and four option years, with an anticipated base period of performance from October 6, 2026, through October 5, 2027. Services will be performed on a labor-hours basis at the SBA Headquarters in Washington, D.C., with an estimated total value ranging between 7.5 million and 9.5 million dollars. The selected contractor will provide personnel to augment the SBA workforce in areas such as delegated authority management, risk diagnostics, and the execution of desktop reviews and financial analyses to assess 7(a) lender risk. Key responsibilities include utilizing federal systems like the Lender Portal and Capital Access Financial System, preparing internal correspondence for stakeholders, and managing loan transfers and invoice resolutions. Required labor categories include an On-Site Supervisor, Financial Analysts, and Program Analysts. Technical and price proposals are due by 9 a.m. Eastern Standard Time on September 21, 2026, and must be submitted via email to the designated point of contact.
Pbs R4 (amd) Acquisition Management Division

POSTED

about 13 hours ago

DEADLINE

in 10 days

AI Contract Overview

Show more

The contract seeks development of computational statistical modules designed to analyze heterogeneous particle suspensions, employing Euclidean distance metrics and Kolmogorov-Smirnov tests to enable robust root cause analysis and detailed distribution comparisons. The work is focused on creating analytical tools that support quantitative insights into particle behavior and variability, crucial for quality assurance and process understanding in regulated environments. The modules must be scientifically rigorous, computationally efficient, and capable of integrating with existing analytical workflows in pharmaceutical or biologic manufacturing contexts. The solicitation is issued as a subcontract under the NAICS code 541611 for scientific and technical consulting services by the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services. Performance is required to occur in Silver Spring, Maryland, with a 20993 ZIP code designation. Proposals must be submitted by May 26, 2026, at 5:00 PM Eastern Time, following a posting date of May 11, 2026. While no set-aside provisions are indicated, the nature of the work implies a technical expertise requirement aligned with advanced data analysis and regulatory compliance standards.

General Info

Development of statistical modules analyzing particle suspensions for FDA, using advanced computational techniques.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541611 - Administrative Management and General Management Consulting ServicesView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA-75F40126Q00142.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Artificial Intelligence and Computational Statistics Platform for Biosimilar Subvisible Characterization

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develop statistical modules for analyzing heterogeneous particle suspensions using Euclidean distance metrics and Kolmogorov-Smirnov tests to support root cause analysis and distribution comparison.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS